RUS      ENG    

Thursday, 15 November 2018

HomeAboutInternational Forum of Cardiology and Internal MedicineRussian Cardio AgendaWorld Cardio AgendaEducational projectsGuidelineslinical trialsJournalsNewsArchive

  • FDA Approves Eluvia Paclitaxel-Polymer Stent for PAD ...
  • Indirect Annuloplasty Device Reduces Mitral Regurgitation ...
  • Antihypertensive Therapy Reduces Alzheimer"s, Dementia Risk ...
  • Studies Find No Easy Predictors of Stroke Prevention in TAVR ...
  • Statins in Peripheral Artery Disease: What Are We Waiting For? ...

    The Department of Health in Moscow
    The State Committee on Health
    Silicea-Poligraf, publishing house

    Follow us:
    @moscowcardio               Facebook

    Information letter        Registration form          Poster of the Moscow cultural program


    The 29th Great Wall International Congress of Cardiology (GW-ICC) was held in Beijing, at the China National Convention Center from October 11 to 14, 2018. More than 22 thousand delegates took part in the work of the congress. Experts from 36 countries and various regions presented reports on 300 areas of cardiology, interventional cardiology, cardiac surgery, comorbidity and prevention. The motto of the congress in 2018 was “Healthy heart work hard”. Joint symposiums with American and European professional societies were organized in the work of the congress. The exhibition was attended by both international organizations and leading global and local pharmaceutical companies. Russia was represented by Professor Mamedov MN with a report on the topic “Comorbidity in Dyslipidemia”.

    Abstracts published in a special issue of JACC:


    Review prepared by the Cardioprogress Foundation

    Cardiovascular diseases (CVDs) are the leading cause of death worldwide, since no other reason causes death of so many people as CVDs do. Statistical indicators of recent years showed that every year 4 million people died of CVD in Europe, of which 1 million were in Russia. However, in recent years, our country demonstrated a positive trend in terms of reducing mortality from CVD. Thus, in 2017, the death rate from cardiovascular diseases for the first time since the beginning of the decade dropped below 600 per 100 thousand people. Last year, 858 thousand people died of diseases of the circulatory system, and this number was 5% less than in 2016. The important merit in the above-said belongs to the implementation of the primary vascular care program. There are more than 593 vascular centers operating in Russia, where new technologies for managing patients with complex conditions like acute coronary syndrome and cerebral stroke are introduced.>>>


    This year we"re asking people around the world to make a promise ... for my heart, for your heart, for all our hearts

    A promise as an individual to cook and eat more healthily, to do more exercise and encourage your children to be more active, to say no to smoking and help your loved ones to stop. A promise as a healthcare professional to save more lives. A promise as a politician to implement an NCD action plan.

    A simple promise… for MY HEART, for YOUR HEART, for ALL OUR HEARTS.

    Cardiovascular disease is the world’s number one killer today. But it doesn’t need to be this way. By making just a few small changes to our lives, we can reduce our risk of heart disease and stroke, as well as improving our quality of life and setting a good example for the next generation. It’s about saying to yourself, the people you care about and individuals all around the world, “what can I do right now to look after MY HEART… and YOUR HEART?”

    Scientific programme

    Results of the European Congress of Cardiology 2018

        The next annual congress of the European Society of Cardiology was held August 25-29, 2018 in Munich (Germany). The Congress of the European Society of Cardiology is one of the three most important and most visited cardiological international scientific events. More than 31 thousand delegates from 150 countries and 5 continents of the world took part in the work of the Congresss >>>


    Weight-Adjusted Aspirin Dosing: Evidence Builds in Primary Prevention

        Low-dose aspirin intended for primary prevention, typically 75 to 100 mg once daily, doesn"t protect against cardiovascular events in persons who weigh at least 70 kg (about 154 pounds), suggests a patient-level analysis of randomized trials that included more than 100,000 patients.

        But daily aspirin at higher dosages, usually at least 300 mg, was cardioprotective in that group, as was low-dose aspirin in people who weighed less than 70 kg.

        What constitutes a "low" or "high" aspirin dosage tends to vary somewhat by world region; regardless, the current findings challenge the common practice of prescribing a "one-size-fits-all" aspirin dosage in primary cardiovascular (CV) prevention, and possibly in secondary prevention>>>

    New ADA/EASD Guidance on Diabetes: Assess CV Status First


        The treatment approach to type 2 diabetes should begin with an assessment of cardiovascular disease (CVD) status, other comorbidities, and patient preferences, according to a draft of the upcoming 2018 joint consensus statement from the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD).

       The final version of the 2018 update to the current 2015 ADA/EASDManagement of Hyperglycemia in Type 2 Diabetes statement (Diabetes Care.2015;38:140-149) will be presented on October 5, 2018 at the EASD annual meeting in Berlin and will be published in Diabetes Care and Diabetologia>>>

    Expert opinion.

    Double antiplatelet therapy after ACS: "de-escalation"

         In medical practice, cases in which patients with acute coronary syndrome (ACS) and received a combination of acetylsalicylic acid (ASA) with prasugrel or ticagrelor are often used, a combination of ASA with clopidogrel is started. This transition from more active platelet-derived P2Y12 blockers to less active clopidogrel has been termed "de-escalation"

         The possibility of "de-escalation" is considered in documents prepared by various expert groups. Among them, an updated version of the recommendations of the European Society of Cardiology and the European Association of Cardio Thoracic Surgeons for double antiplatelet therapy for coronary heart disease, where a similar transition is proposed to be discussed with side effects or intolerance of prasugrel / ticagrelor. There is also an agreement of experts from Europe and the USA, in which practical approaches to the replacement of the P2Y12 blocker of the platelet receptor are analyzed in detail. However, it should be borne in mind that these proposals are basically based on common sense and representations of the pharmacological properties of various P2Y12 receptor blockers of the platelet, while the evidence base for "de-escalation" is small.>>> 


    Today is World No Tobacco Day!

     We are delighted to be working with the World Health Organization (WHO) for this year’s World No Tobacco Day (WNTD) on May 31, under the theme ‘Tobacco Breaks Hearts’, which aims to highlight the negative impact of tobacco on cardiovascular health.



    Global resolution on Rheumatic Fever and Rheumatic Heart Disease adopted at the WHA


       Following years of campaigning and advocacy from WHF, our members and the global RHD community, we are delighted to announce that on Friday 25 May, Member States of the World Health Organization unanimously adopted a Global Resolution on Rheumatic Fever and Rheumatic Heart Disease at the World Health Assembly in Geneva, Switzerland>>>

     Conference News: HRS 2018


      A first randomized comparison of catheter ablation vs rate-control or rhythm-control drug therapy for atrial fibrillation (AF) wasn"t the invasive procedure"s moment of truth some in the field had anticipated.

      No significant difference in a composite clinical primary endpoint, or in mortality, was seen for the two approaches to treating AF in the open-label Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) trial, in a follow-up of about 4 years>>>

      The Cardioprogress Foundation with the help of volunteer young doctors held an action on the Red Square on May 9 to conduct a preventive examination of the veterans of the Great Patriotic War, participants in the Victory Parade and the Immortal Polk.

       On this day, all those wishing to spend a measurement of blood pressure, preventive conversation on a healthy lifestyle and general medical recommendations.




    Bread Might Be The Saltiest Part Of Your Diet, According To A New Study

       Over a third of breads have too much salt, according to a new study. Here"s what that could mean for your health.


       Even though it doesn"t taste that salty, bread might be delivering more sodium than you think — but it all depends on which kind you eat and how much, according to a new study.

    Researchers analyzed 2,000 different breads (including white, wholemeal, mixed grain, and flatbreads) sold in 32 countries around the world and found some shockingly high numbers and wide variation in the salt and sodium levels in breads>>>


         The joint Franco-German non-commercial television network ARTE recently broadcast a television programme entitled "The Big Bluff" about the link between cholesterol, cardiovascular disease, and the use of statins. The programme propounded the theory that there is absolutely no relation between blood cholesterol levels and cardiovascular disease, and asserted that cholesterol has become the "ideal villain" in cardiovascular disease through a series of "scientific approximations". In addition, the programme encouraged physicians and patients to interrupt lipid-lowering treatments and statins>>>


    Coffee Consumption and Coronary Artery Calcium Score: Cross‐Sectional Results of ELSA‐Brasil (Brazilian Longitudinal Study of Adult Health)


    Background Available evidence for the relationship between coffee intake and subclinical atherosclerosis is limited and inconsistent. This study aimed to evaluate the association between coffee consumption and coronary artery calcium (CAC) in ELSA‐Brasil (Brazilian Longitudinal Study of Adult Health). 

    Methods and Results This cross‐sectional study is based on baseline data from participants of the ELSA‐Brasil cohort. Only participants living in São Paulo, Brazil, who underwent a CAC measurement (n=4426) were included. Coffee consumption was collected using a food frequency questionnaire. CAC was detected with computed tomography and expressed as Agatston units. CAC was further categorized as an Agatson score ≥100 (CAC ≥100)>>>



                A new  version of the European Heart Rhythm Association (EHRA) practical guide on non–vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) aims to help physicians navigate various new data — including some just presented last month in the United States — but also a more complex clinical landscape.

                "As health care providers get more comfortable using NOACs, treatment of more complex patients, such as the elderly, frail, those with multiple co-medications, is getting increasingly more common. We felt that not only an update but a fully revised version would be appropriate," writing committee chair, Jan Steffel, MD>>> 

    Information letter            Registration form              Short scientific program         Full version of the scientific program

    Poster of the Moscow cultural program       Abstract book      Invitation letter       Press Release

    The diary of the first day        The diary of the second day       The diary of the third day 


    • 18,300+ Attendees • Nearly 13,000 Professional Attendees • 280 Exhibitors
    • Key Opinion Leaders from 137 Countries • 325+ Press representing 174 media outlets


     MOMENTUM 3: HeartMate 3 Improves Stroke-Free Survival at 2 Years

    TRIUMPH: Triple Low-Dose Combo Pill a Success in Hypertension

    Barbershop-Based Healthcare Cuts Hypertension in Blacks

    Music Boosts Exercise Capacity During Cardiac Stress Test >>>



    19.7% OF ECONOMY BY 2026


                By 2026, healthcare is projected to make up 19.7% of the US economy, up from 17.9% in 2016, according to a report released today by the Office of the Actuary at the Centers for Medicare & Medicaid Services (CMS).

                Spending is projected to be $5.7 trillion by 2026, up from $3.5 trillion now. CMS projects that federal, state, and local governments will be financing 47% of that spending, up from 45% in 2016, partly related to the aging of the population.

                The report, published online in Health Affairs by Gigi Cuckler, an economist in the Office of the Actuary in Baltimore, Maryland, and colleagues projects an average annual growth rate in health spending of 5.5% through 2026, which would outpace average projected growth in gross domestic product (GDP) by 1 percentage point. GDP is expected to grow 4.5% per year in that period>>>



    High blood pressure should be treated earlier with lifestyle changes and in some patients with medication – at 130/80 mm Hg rather than 140/90 – based on new ACC and American Heart Association (AHA) guidelines for the detection, prevention, management and treatment of high blood pressure. The new guidelines – the first comprehensive set since 2003 – also stress the importance of using proper technique to measure blood pressure; recommend use of home blood pressure monitoring using validated devices; and highlight the value of appropriate training of health care providers to reveal “white-coat hypertension.”

                Visit the ACC’s High Blood Pressure Guidelines Hub:


    ACADEMICIAN RAFAEL G. OGANOV (on the occasion of his 80th birthday)

    On December 9, 2017, the well-known Russian cardiologist, scientist, clinician, doctor of medical sciences, professor, academician of the Russian Academy of Sciences, honored scientist of the Russian Federation, laureate of the Russian State Prize, honorary president of the Russian Cardiological Society, editor-in-chief of the 2 leader Russian cardiology journals Oganov Rafael.  Rafael Oganov was born in a working family in Moscow. He passed a great life and creative path from a clinical resident to an academician of the RussianAcademy of Medical Sciences, a scientist, a doctor and a teacher widely known in Russia and abroad.>>>

    Scientific program


     We look forward to networking with other World Heart Federation Members and international cardiology 

    experts at the next World Congress of Cardiology & Cardiovascular Health to be held in Dubaiin 2018. Come join us! 

    On behalf of Cardioprogress Foundation let us sincerely congratulate you with the World Heart Day!

                World Heart Day is celebrated annually starting from 1999, more than in 100 countries around the globe in the last Sunday of September. And in 2011, the World Heart Day. And from 2011 it has its own confirmed date- the 29th of September. Events, that take place during the World Heart Day are attract attention to the problem of cardiovascular diseases, it"s the world"s biggest intervention against these conditions. It’s utterly important to show the world the importance of healthy life style, and the influence of bad habits on the cardiovascular system.

    Since 2013 Cardioprogress Foundation is associated member of World Heart Federation and is taking part in every arrangement of the WHF.>>>





    Hypertension is common among patients with diabetes, with the prevalence depending on type and duration of diabetes, age, sex, race/ethnicity, BMI, history of glycemic control, and the presence of kidney disease, among other factors (1–3). Furthermore, hypertension is a strong risk factor for atherosclerotic cardiovascular disease (ASCVD), heart failure, and microvascular complications. ASCVD—defined as acute coronary syndrome, myocardial infarction (MI), angina, coronary or other arterial revascularization, stroke, transient ischemic attack, or peripheral arterial disease presumed to be of atherosclerotic origin—is the leading cause of morbidity and mortality for individuals with diabetes and is the largest contributor to the direct and indirect costs of diabetes. Numerous studies have shown that antihypertensive therapy reduces ASCVD events, heart failure, and microvascular complications in people with diabetes (4–8). Large benefits are seen when multiple risk factors are addressed simultaneously (9). There is evidence that ASCVD morbidity and mortality have decreased for people with diabetes since 1990 (10,11) likely due in large part to improvements in blood pressure control (12–14). This Position Statement is intended to update the assessment and treatment of hypertension among people with diabetes, including advances in care since the American Diabetes Association (ADA) last published a Position Statement on this topic in 2003 (3). >>>


    Higher coffee intake is linked to significantly lower risk for death, two large studies confirm. The benefit was found in diverse European populations, as well as across different racial/ethnic groups, researchers report in articles published online today in Annals of Internal Medicine.

                Because coffee is one of the most popular drinks in the United States and worldwide, the public health effect of coffee intake could be substantial, even if the effect on an individual is small.

    Despite mounting evidence for the health and mortality benefits of coffee consumption, the relationship between coffee intake and mortality in different European populations in which coffee preparation methods vary has been unclear. Similarly, data on coffee drinking among nonwhite populations were lacking.>>>


    The European Journal of Cardiology published an article by Professor Mekhman N Mamedov on the activities and prospects for the development of the International Heart and Vascular Diseases Journal. We invite you to review the contents of this publication.



    A very focused issue on “Advances in Cardiovascular Disease Prevention” has been published in Cardiovascular Diagnosis and Therapy(CDT). It was our honor to invite its Guest-editors Prof. Nathan D. Wong and Prof. Ian Graham for an E-interview.

    Prof. Nathan Wong is a cardiovascular epidemiologist and Professor and Director, Heart Disease Prevention Program, Division of Cardiology at the University of California, Irvine in California. He holds MPH and PhD degrees in epidemiology from YaleUniversity. He is a past president (2010–2012) of the American Society for Preventive Cardiology. He is also a fellow of the AmericanCollege of Cardiology, American Heart Association, National Lipid Association, and American Society for Preventive Cardiology and is the current treasurer of the Pacific Lipid Association, and is on the board of directors of the InterAmerican Heart Federation and California Chapter of the AmericanCollege of Cardiology. He also serves on the Member Services and Credentialing Committee and Prevention of Cardiovascular Disease Committee of the AmericanCollege of Cardiology and is past chair of the American Heart Association Prevention Science Subcommittee.>>>




       Prolonged television viewing is associated with an increased mortality risk, including from cardiovascular disease (CVD), that may be at least partially mediated by inflammatory markers, suggest results from a large UK cohort study[1]. The findings, which were published online on June 9, 2017 inAtherosclerosis, demonstrate for the first time that over 15% of the association between mortality and increased TV viewing may be explained by C-reactive protein and fibrinogen levels. Dr Mark Hamer (National Centre for Sport and Exercise Medicine, East Midlands, Loughborough, UK) and colleagues note that previous research has shown that prolonged sitting is linked to the expression of genes associated with inflammatory responses. "Fibrinogen, the strongest predictor of mortality in the present study, may also have relevance in terms of elevated risk of vascular conditions, particularly venous thrombosis," they write. "Recent experimental data demonstrated increases in plasma fibrinogen with prolonged uninterrupted sitting that was attenuated with active breaks.">>>


    All of Us, the Precision Medicine Initiative that aims to revolutionize the path to improving health, has launched its beta phase, according to Program Director Eric Dishman. In a video announcing the launch, Dishman said on Tuesday, "This has been a long time coming, but it"s a huge milestone. 

    "Over the next 4 to 5 months," he said, "the first 10,000 to 15,000 people will be recruited across more than 100 locations around the country, but you have to have a code to get in." The University of Pittsburgh Medical Center in Pennsylvania is the kickoff site and has enrolled the first participants.

     This phase will allow the program"s leaders to tweak the messaging, videos, and protocols and test systems. Public sign-up is set to begin in the fall. The program, which began with a State of the Union address by President Obama in 2015, intends to get at least 1 million volunteers to sign up to contribute information on their genetic makeup, environmental factors, lifestyle choices, medical histories, and personal device and sensor data. As reported in Medscape Medical News, the program is popular. A nationalsurvey found that 8 in 10 US adults support the effort, and more than half (54%) plan to volunteer their data. Support was consistent across most demographic groups. Since last July, leaders have established a network of medical centers, universities, technology companies, and community partners to enroll participants and collect data and blood and urine samples. Pilot studies and focus groups have gauged what the public wants from the project and what people have concerns about. "By providing information about their health, lifestyles, and environments over the course of many decades, these volunteers will be important partners in helping create an unprecedented research resource to drive future discoveries. This resource will be easily accessible to researchers of all kinds, from citizen scientists to investigators in academia and industry, for studies on a variety of health topics," Dishman said in a statement.


    Since women make up about half of all medical students, the glaring gender gap in cardiology deserves attention.

                Dr Robert Harrington of Stanford called the dearth of women in cardiology a talent issue for our field. In a tweet, he noted that women make up 45% to 47% of internal medicine residents but less than 20% of cardiology fellows. And it"s worse in the lab-based subspecialties, where <10% of interventional cardiology or electrophysiology fellows are women.

                My private-practice group is unusual; 42% of partners are women. I asked them about the gender gap.

                Dr Rebecca McFarland, a mother of many (n=6), was first to respond to my emailed questions.

                "I laugh as I read [your email] because I"m sitting in a neighborhood waiting to pick up my son after soccer practice. I haven"t picked up a journal in about a week and I"m thinking about how to disperse my crew of kids to the various and sundry engagements that they have in the next 3 days. Never mind that I start call tomorrow morning [and] probably won"t surface to see the sunlight until Sunday night. Hmm . . . why aren"t there more women doing this?" >>>



    May 17 - 20, 2017Paris, France


    In ACS, Less Bleeding With Two-Step Post-PCI DAPT Strategy

    Transradial Access May Mitigate Acute Kidney Injury in ACS

    Novel 2.0-mm Stent Promising for Super Small Coronary Vessels

    REPRISE 3: Device Efficacy Favors Lotus Over CoreValve  



    Professor David Wood, WHF President, on participating in the 70th World Health Assembly


    Today marks the opening of the 70th World Health Assembly (WHA), one of the highlights of the global health calendar. At this annual conference, Ministers of Health, civil society and World Health Organization (WHO) experts will meet to discuss the most pressing health issues of our time, including cardiovascular disease (CVD).  

    As President of the World Heart Federation, I am delighted to welcome a large delegation of member partners, members, Board and staff to the event. Through our leading position in cardiovascular health, we aim to raise the profile of CVD to ensure that global health policies meet the needs of patients and our global membership.

    In addition to a packed agenda, many WHA attendees are focused on the election of the next Director-General of the WHO, as Dr Margaret Chan steps aside after 10 years in the post. There are three excellent candidates in the running: Dr Tedros Adhanom Ghebreyesus, Dr David Nabarro and Dr Sania Nishtar. >>>


            Congress highlights EAS 2017 Prague, Czech Republic

                                                                             April 23 -26                                                                        

    85th EAS Congress Opens with a light touch of Prague magic!

    New EAS President Professor Lale Tokgözoğlu (Hacettepe University, Ankara, Turkey)welcomed all to what promises to be an exciting programme at this year’s Congress. This year’s Congress has broken all past records, with over 2300 delegates attending from across the globe, reaffirming the unique position of EAS at the forefront of research, education and advocacy. And as EAS Congress Chair Professor Michal Vrablik (Charles University in Prague, Czech Republic) clearly reminded delegates: ‘You are the most important participants at Congress: learn, discuss and most importantly, don’t forget to network!’

    2017 Anitschkow Award recipient, Professor Alan Tall (Columbia University, New York, USA) gave an intriguing lecture covering highlights of his research in lipoproteins, including his role in elucidating the part that cholesteryl ester transfer protein (CETP) plays in the regulation of human lipoproteins, providing an impetus to the development of the CETP inhibitors. The development of these agents has, however, followed a rocky road, which may in part relate to off target effects, unanticipated effects on reverse cholesterol transport, as well as underpowered and too short clinical trials. Professor Tall confirmed that the REVEAL (Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification) study with anacetrapib has now been completed and results are anticipated in the summer.

    The leading international congress in preventive cardiology was held from 6 to 8 April 2017 in Malaga (Spain)

    It provides the opportunity for clinicians and scientists from all over the world to gather, to learn about new advances and to exchange scientific ideas and knowledge in a distinctive environment. Innovation and research are essential components of medical practice which evolves daily as a result of this coming together of technology, knowledge and process. By focusing on ‘Innovations in Preventive Cardiology’ EuroPrevent 2017 aims to explore which novel ideas, opportunities, data or technologies could have an impact on society and what that impact could mean.

    Scientific program and video materials are available on the website  


    Jean-Luc Eiselé takes over as World Heart Federation Chief Executive Officer, effective from 1 May 2017


    David Wood, World Heart Federation (WHF) President, comments:

    "I am pleased to inform you that Jean-Luc Eiselé (MSc, PhD) has been offered and accepted the position of WHF Chief Executive Officer, effective from 1 May 2017.

    "Jean-Luc is a dynamic leader who has distinguished himself at the interface of the non-profit, academic and industry communities. With extensive international experience in the field of association management, public health and advocacy, he joins us from Les Ligues de la santé which has a focus on primary prevention and health promotion. Prior to this, Jean-Luc was Executive Director of the FDI World Dental Federation responsible for developing global and national advocacy activities, and successfully launching and developing World Oral Health Day. "The Board were impressed with Jean-Luc"s excellent track record, especially at the World Dental Federation and European Respiratory Society, and by the high regard in which he is held by both organizations. He has a deep understanding of the priorities and challenges of a non-profit and member organization, and is committed to adding value to our members. He also has significant experience of working in low- and middle-income countries, which are priority areas for WHF.

    "Along with his proven leadership in advocacy and contributions to the NCD agenda, we believe that Jean-Luc has the skills and experience to help take the WHF to a new level of engagement with our mission to prevent cardiovascular diseases and we are delighted to welcome him on board." 

    Photoreport from the VI International Forum of Cardiology and Internal Medicine

    Information letter           Scientific program              Abstract book          Official invitation           Registration 



    • Fewer Re-PCIs After Primary PCI Plus FFR-Guided Intervention
    • Clinical Outcomes Trials Put iFR in Same League With FFR
    • Rivaroxaban Doesn"t Increase Post-ACS Bleeding vs Aspirin: Study
    • ABSORB-3 at 2 Years: More CV Events With Absorb BVS vs Xience
    • Brisk Walking Can Help in Hypertrophic Cardiomyopathy
    • EINSTEIN CHOICE: Rivaroxaban Beats Aspirin for VTE Recurrence
    • LDL-C Plunges on Novel Anti-PCSK9 Agent Inclisiran: ORION-1
    • FDA Warns of CV Event Risk With Absorb BVS
    • SPIRE Trials: Immune Response Thwarts PCSK9 Inhibitor Bococizumab
    • SURTAVI: TAVR, SAVR Stand Toe-to-Toe in Intermediate-Risk Patients
    • Evolocumab Added to Statins Cuts CV Events in FOURIER Trial
    • PCSK9 at ACC Sessions Joins Washington, DC, Acronym Alphabet Soup


     Genetic Risk Could Guide Heart Disease Prevention

    The use of genetic sequencing to identify which patients would benefit most from aggressive statin therapy for the primary prevention of a heart attack could soon be a clinical reality. And the discovery of genetic mutations associated with cardiovascular disease — but not linked to any known risk factors — opens the possibility of novel therapies to help people cut the risk for future events.>>>

     Dear women, and colleagues! ardioprogress Foundation congratulates you 
    on International Women"s Day!


    Mediterranean Diet With Olive Oil Boosted HDL Function?

    More research suggests that a Mediterranean-style diet supplemented with either virgin olive oil or mixed nuts enhances the function of HDL cholesterol[1].

    In a subset of 296 patients at high risk of heart disease in thePREDIMED study, cholesterol efflux capacity (CEC), the first step in reverse cholesterol transport, was significantly increased at 1 year compared with baseline in those advised to eat a Mediterranean diet rich in virgin olive oil (VOO) (P=0.018) or mixed nuts (P=0.013) rather than a reduced-fat diet.

    In addition, both Mediterranean-diet groups had a trend toward improved antioxidant and endothelial functions of HDL, although the changes were statistically significant only in the Mediterranean diet–VOO group.>>>

    Trump Pick for CMS Would Ease Up on Physicians

    Seema Verma, MPH, President Donald Trump"s choice to head the Centers for Medicare & Medicaid Services (CMS), has mixed feelings about electronic health record (EHR) systems. It"s just one example of how she"s on the same page with many physicians regarding healthcare. "My doctor…is staring at her computer instead of looking at me," the healthcare policy consultant told the US Senate Committee on Finance during her confirmation hearing yesterday.

    Verma"s comment came in response to a question about the future of the CMS incentive program for meaningful use of EHRs, much criticized by physicians for turning them into data entry clerks. She also recounted seeing signs in physician waiting rooms that apologized for schedule delays due to EHR implementation. Yet another tech challenge she cited was the lack of EHR interoperability, which prevents different programs from freely exchanging data.>>>

      WHF & NCD Alliance joint statement on NCDs at the heart of SDGs

    In a joint statement delivered by WHF"s Alastair White, the World Heart Federation and NCD Alliance advocated for NCDs to be placed at the heart of the 2030 Agenda for Sustainable Development. Highlighting the central role of health in sustainable development, the statement called for intersectoral partnerships, stronger health systems and adequate and sustained financial resources to help countries achieve the Sustainable Develop ment Goals.


    November 12 - 16, 2016New Orleans, Louisiana


    Clinton and Trump Tangle on Preserving Medicare 

    Democrat Hillary Clinton said she would keep Medicare and Social Security solvent with "more resources and smarter decisions," while Republican Donald Trump prescribed a booming economy to preserve the programs in the third and final presidential debate at the University of Nevada, Las Vegas.

    Clinton explained what she meant by "more resources."

    "We are going where the money is," she said on the subject of paying for her ambitious domestic spending agenda. "We"re going to ask the wealthy and the corporations to pay their fair share."

    When debate moderator Chris Wallace of Fox News asked Trump how he would keep Medicare and Social Security afloat, the real estate developer and TV reality-show star replied, "We"re going to grow the economy. It"s going to grow at a record rate." 

    "But that"s not going to help entitlements," replied Wallace.

    "It"s going to totally help you," replied Trump, without explaining how. He then proceeded again to declare that the Affordable Care Act (ACA) must be repealed and replaced. He cited premium increases for exchange policies of 60% to 80% that, according to fact-checkers at the nonpartisan news organization PolitiFact, represent outliers, as opposed to an average increase of anywhere from 4.4% to 13%.>>> 



    Russian National Congress of Cardiology 2016: the main results

     20-23 September 2016 in Yekaterinburg hosted the annual Russian National Congress of Cardiology. According to the organizing committee of the congress was attended by about 5,000 participants from more than 150 Russian cities and 20 countries around the world. The scientific program consisted of 169 sessions with the participation of lecturers from Russian regions and 17 foreign countries. The program was organized by 3 poster sessions and two plenary sessions too. The scientific program covered a wide range of issues: from epidemiology, diagnostic methods - before the treatment and rehabilitation of patients with cardiovascular diseases.  >>>


    World Heart Day. Photo report from Russian events. 

     World Heart Federation calls on governments to increase efforts to prevent and control the growing epidemic of cardiovascular disease (CVD), the number one cause of death in the world. The World Heart Federation (WHF) is today issuing a global policy call to governments around the world to implement reliable and fit for purpose surveillance and monitoring systems for cardiovascular disease (CVD) in order to better prevent, treat and control the world’s biggest killer. CVD - including heart disease and stroke - is the leading cause of death globally, claiming 17.5 million lives each year. However, at least 80% of premature deaths from CVD could be avoided1 by addressing risk factors such as tobacco use, raised blood pressure and physical inactivity; and improving the use of simple treatments after a heart attack or stroke.>>> 



    ESC CONGRESS 2016 (Rome, Italy) 


           ESC CONGRESS 2016, the world’s largest and most influential cardiovascular meeting, promises to feature world class science that will be more interactive than ever before. Over the next five days 150 different topics will be covered in over 500 sessions attended by over 30,000 professionals from 106 countries. ‘We warmly welcome everyone to ESC Congress 2016, held for the first time in the eternal city of Rome,’ says Geneviève Derumeaux, Chair of the Congress Programme Committee. ‘I think that the ethos of ESC Congress can be summarised by the words of the great Italian film director Federico Fellini. ‘‘There is no end. There is no beginning. There is only the infinite passion of life.’’ For me, this shows how all the advances in cardiovascular medicine are based on the tireless work of clinicians and scientists who went before.’

    As ever, the big highlight will be original research, with the programme including:

    • 28 clinical Hot Line studies

    • 26 clinical trial updates

    • 24 registry studies

    • 12 basic and translational science Hot Lines

    • 4594 abstracts selected from more than 11,000 submissions.

     See more: 

    Lipids Management European Style: EAS President Interviewed

    The 2016 European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) guidelines on cardiovascular disease prevention in clinical practice continue to include risk-based low-density lipoprotein cholesterol (LDL-C) targets despite a change in US guidelines. Alberico L. Catapano, PhD, president of the EAS and a professor of pharmacology at the University of Milan, explains why to | Medscape. | Medscape: Despite the change in the US guidelines to move away from lipid targets, the 2016 ESC/EAS guidelines on cardiovascular disease prevention in clinical practice[1] include risk-based LDL-C goals for patients. Why did you choose that approach?>>>


    Keep Sex in the Discussion With Coronary Heart Disease Patients


    Older patients with coronary heart disease (CHD) are less likely to be sexually active than those without CHD, but a new study suggests that resuming an active sex life puts them back on track with their peers[1].

    Assessing data on 6690 men and women aged 50 and older, UK researchers found that CHD was independently associated with an adjusted 38% reduction in the odds of reporting any sexual activity in men (odds ratio [OR] 0.62, P<0.001) and a nonsignificant decline of 9% in women (OR 0.91, P=0.058).>>>


    Top 10 Causes of Death in the US


    The death rate in the United States hit an all-time low in 2014. For the age-adjusted death rate of 724.6 deaths per 100,000, down 1% from 2013, heart disease and cancer were still the top two causes of death in the United States in 2014, according to new data from the National Center for Health Statistics published June 30 in National Vital Statistics Reports>>>


    The Hidden Value of a Patient"s Social History


    The "Good Old Days" of Paper Charts

    Cynics and neo-techno luddites will forever lament the loss of the elegance and availability of the written word, particularly when it comes to the paper medical chart. There are some things to be said for this position. But, to be fair, there have been opportunities that were missed or not taken advantage of in both the eras of the written chart and the electronic health record (EHR).

    In particular, the social history section has long been misunderstood and underutilized. No, I"m not going to enter into the old axiomatic debate of whether substance use belongs in the medical history or social history. Instead, I"m speaking of taking full advantage of the "social" aspect of the social history.>>>

    Congratulations  of Carioprogress Foundaton

    on the Day of medical worker

    Dear colleagues!

    By tradition, on the third Sunday of June in Russia marks the Day of the medical worker.

     Medical profession - one of the toughest in the world. Learn her long and sometimes difficult, but the results of this work surpass all expectations - it smiles and gratitude rescued people and their loved ones.

    No one, even the most modern device is no substitute for professionalism and skills of health workers, sensitivity and careful attention to the patient. Please accept our warm and sincere congratulations on our professional holiday!


    Despite "Exploding" Use, TAVI Still Too Costly in Many Countries

    A survey of transcatheter aortic-valve implantation (TAVI) in 2014 in 21 countries excluding Western Europe, Canada, and the United States revealed that less than half of eligible patients underwent this procedure, and the biggest barrier was financial constraints[1].

    Market research analyst Dario Remigi (BIBA Medical, London, UK) presented these findings here on June 7, 2016 at the World Heart Federation"s World Congress of Cardiology & Cardiovascular Health 2016 (WCC 2016). >>>


    A consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel

    Familial hypercholesterolemia (FH) is a frequent genetic disease associated with elevated and precocious  risk of cardiovascular disease (CVD). Recent advances in molecular diagnosis and the publication of epidemiological and case control studies have allowed to better understand the heterogeneous phenotype and the risk of CVD in FH patients. Indeed, there is a big overlap among severe forms of FH and the classical concept of homozygous and heterozygous forms is no longer precise when CVD risk is concerned. Despite the importance of the genotype, what determines the CVD risk is actually the phenotype (elevated cholesterol levels), the concomitance of other atherosclerotic risk factors, and the presence of clinical and subclinical atherosclerosis. Fortunately there has been an enormous advance in the treatment of FH, with the onset of PCSK9 inhibitors and medications that reduce the production of LDL  thus allowing reductions in LDL-cholesterol beyond what we had so hardly achieved in the past.However, these newer treatments have an elevated cost and must be used in the highest risk for CVD patients for the best cost-effectiveness. The International Atherosclerosis Society Severe FH Panel worked with the objective of characterizing the severe FH phenotype and made recommendations on how to stratify CVD risk and  whom to prescribe the novel lipid lowering treatments. These recommendations  will  contribute to the daily clinical practice and better management of FH patients. The document is published in the Lancet Diabetes and Endocrinology,  has open access  after registration on the journal’s website,  and the  weblink is



    PROGRAMME BOOK                  PLENARY SESSION                  KEYTONE LECTURE 

    The World Congress of Cardiology & Cardiovascular Health 2016 taking place in Mexico City 4-7 June will be a platform to showcase and share the best of cardiovascular health, from medical practice to public health approaches such as tobacco control, making this event relevant to everyone from clinical cardiologists and nurses to policy makers and health economists.
    This is where all aspects of heart health meet!

    Discover the scientific programme and be sure to register before 13 May!

    If you are in Latin America click here for our regional offer which also expires 13 May:Spanish or Portuguese.


    Rheumatic Heart Disease (RHD)

    To achieve its mission of reducing RHD around the world, the World Heart Federation has set a specific goal:25x25<25

    Rheumatic heart disease (RHD) is a preventable, treatable form of cardiovascular disease (CVD) that affects over 32 million people around the world and claims 275,000 lives annually. It affects the world’s poorest, most vulnerable populations and imposes heavy costs on the health systems that can least afford it. If left untreated, rheumatic heart disease can lead to heart valve damage, stroke, heart failure, and death. Treatment of advanced disease requires costly surgery that is unavailable in many parts of the world. In endemic countries, prevalence of this preventable disease is a stark measure of health system failure and inequality. >>>


    12 Smart Time Management Tips for Doctors

    Physicians are swamped: heavy patient loads, mountains of administrative demands, endless team and departmental meetings, and the list goes on. The result? Patients are kept waiting. Work becomes less enjoyable. Stress builds; and "expendable" activities, such as exercise, family time, and sleep, are jettisoned.

    Part of the problem, experts say, is that most people, including physicians, aren"t trained to manage their time. While time management is an integral part of many corporate management training programs, medical training is about "triaging emergencies," says Dr Craig Gordon, a nephrologist and assistant professor of medicine at Boston University Medical Center. "We are trained how to be busy, so we don"t stop to ask questions like, "Is this the best way?" and, "How do I want to spend my time?"">>>


                                                                         “Cardioprogress” Foundation Press Release 

    Results of V International Forum of Cardiology and Internal Medicine

    V International Forum of Cardiology and Internal Medicine was successfully held in Moscow, Russian, in the New building of Russian Academy of Sciences Presidium on March 29-31, 2016 . The work of Forum has been supported by the Ministry of Healthcare of the Russian Federation, the World Heart Federation, Moscow City Department of Healthcare, Federal State Institution National Research Center for Preventive Medicine of the Ministry of Healthcare of the Russian Federation, Russian society of Cardiology and Foundation for the Advancement of Cardiology “Cardioprogress”.

    Rafael G Oganov was the chairman of the Forum, Mehman N Mamedov was the chairman of organizing committee and Jurii A Vas’uk was the chairman of scientific committee.>>>





    · 19,000+ Attendees ·  More than 13,800 Professional Attendees

    ·  280+ Exhibitors ·  Key Opinion Leaders from 110 Countries

    ·  235 Press representing 165 media outlets

    ·  Medical Devices and Equipment  · Pharmaceuticals  · HealthIT  · Imaging

    ·  Diagnostics ·  Publications and Continuing Medical Education



    More information at


    Informattion letter             Welcome address            Registracion form

     Hypertension in Pregnancy Portends Lasting Cardiomyopathy Risk

    Hypertensive disorders in pregnancy (HDP) are associated with an increased risk of cardiomyopathy years after an affected pregnancy and regardless of hypertension severity, a large registry study involving one million Danish women shows[1].

    "The fact that we could drop the first 5 years after pregnancy and still see this risk was really fascinating," senior author Dr Heather Boyd (Statens Serum Institut, Copenhagen, Denmark) told heartwire from Medscape.>>>



    Primary Care and Hospitalists: Improving the Relationship 

    Cheryl Pegus, MD, MPH

    director of the Division of General Internal

     Medicine and Clinical Innovation at

    New YorkUniversityLangoneMedicalCenter.

    In the past 15 years, we"ve seen the growth of a new specialty, hospital medicine, which started at the end of the 1990s.[1] The term "hospitalist" was coined by Dr Robert Wachter for physicians who spent most of their time taking care of patients in the hospital. This specialty came into being because these patients were sicker, required more complex care, and required real-time care with physicians being present. Hospitalists today are the fastest-growing specialty physicians in the United States.>>>

    Proton Pump Inhibitors Linked to Dementia

    A new study has confirmed an association between proton pump inhibitors (PPIs) — drugs that treat heartburn, peptic ulcers, and other acid-related disorders of the upper gastrointestinal tract — and increased risk for dementia in older patients.>>>

    Regular Sugary Beverages Worsen Long-Term Visceral Adiposity


    More research is suggesting that sugary drinks are more sour than sweet when it comes to adverse health outcomes. New findings from the Framingham Heart Study showed that regular consumption of sugar-sweetened beverages (SSB) changed both quality and quantity of visceral adipose tissue in middle-aged adults[1].In the analysis of 1003 participants in Framingham"s third-generation cohort, those who had the highest intake of SSB, drinking at least one serving daily, had a significantly greater increase in volume of adipose tissue than those who did not drink these beverages at all (P<0.001). They also had a greater decrease in visceral adipose tissue attenuation at computed tomography (CT) imaging (P=0.007). There were no significant differences in abdominal adipose tissue changes between those who did and did not drink diet sodas. >>>

     Cancers May Impair Heart Function, Even Without Chemo: More Evidence

    More research is suggesting a possible relationship between cancer itself and the development of CHD.

    In a new study of 99 total participants with normal ejection fraction (LVEF >55%), myocardial dysfunction, as shown with reduced strain measurements, was similar between patients with cancer who did and did not take cancer drug therapies. In addition, the strain rates for both groups were significantly lower than age- and sex-matched healthy individuals without cancer (P<0.05).>>>


    International Congress of Cardiology "Great Wall" is recognized as a leader among cardiac event Asia-Pacific region


    Great Wall International Congress of Cardiology (GW-ICC) is one of the largest congresses in cardiology in the Asia-Pacific region. Congress was founded in 1990 as a regular technical training course titled "International Training Course on the Great Wall - the China-American Seminar on radiofrequency ablation". In the first scientific event was attended by at least 100 doctors. In 1995, the GW-ICC has positioned itself as a platform for in-depth training and academic exchange, covering areas such as coronary heart disease, heart failure, hypertension, interventional arrhythmology. According to the organizers, the aim of this project is the rapprochement between China and the international cardiology community. Currently, Congress is the largest, most influential and successful event for cardiovascular diseases in the Asia-Pacific region.>>>







    Hot news from the

    American Heart Association (AHA) 2015 Scientific Sessions

    November 7 - 11, 2015; Orlando, Florida



    CABG Preferable to PCI for Multivesse  Disease in Diabetics: Canadian Registry

    Focus More on % LDL Reductions: New JUPITER Data


    Caffeine-Loaded Energy Drink Increases Blood Pressure


    IVUS-Guided PCI With Xience Stent Reduces Target Lesion Revascularization at 1 Year

    EVITA: Varenicline Started in ACS Hospitalization Can Help Smokers Quit

    Valve Prosthesis Beats Repair for 2-Year Durability in Severe Ischemic MR





    Programming Navigation                       Chair"s Welcome                       Late-Breaking Clinical Trials


                                                                                                 Press release of Cardioprogress Foundation 




    Report on the 14th European Congress of Internal Medicine (ECIM 2015) and X Russian National Congress of Internal Medicine


    In Moscow, the International Exhibition Centre "Crocus Expo" from 14 to 16 October 2015 was held on the 14th European Congress of Internal Medicine (ECIM 2015), and X National Congress of Internal Medicine. It is noteworthy that such an international event in the field of therapy in Russia for the first time. Organizers of joint scientific forum are the Ministry of Health, Social Policy Committee of the Federation Council, RussianAcademy of Sciences, Russian Scientific Medical Society of Internal Medicine, the International Society of Internal Medicine (ISIM) and the European Federation of Internal Medicine (EFIM).


    At the opening ceremony were greeted President RNMOT, academician A.I. Martynov, Minister of Health of the Russian Federation V.I.Skvortsova, president EFIM F. Bosch (Netherlands), Secretary General of the World Society of Internal Medicine JP Kohler (Switzerland), as well as heads of the Internal Medicine Society’s of the EFIM country- members.>>>






    From the 22th to 25th of September in Moscow annually Russian National Congress of Cardiologists was held.

    The Congress was dedicated to the fight against cardiovascular disease and the search of new ways of helping patients with these conditions, and also introducing the most modern treatments and innovative methods into practice.

    According to the organizers 6179 doctors have attended this meeting, from both the Russian Federation and 26 other countries. 2176 of the doctors have stated their will to participate in persistent medical educational system and they were able to obtain the Ministry of Health’s certificates. The collection of scientific proceedings was published.>>>



    World Heart DAY: Russian activity


    On behalf of Cardioprogress Foundation let us sincerely congratulate you with the World Heart Day.

    World Heart Day is celebrated annually starting from 1999, more than in 100 countries around the globe in the last Sunday of September. And in 2011, the World Heart Day. And from 2011 it has its own confirmed date- the 29th of September. Events, that take place during the World Heart Day are attract attention to the problem of cardiovascular diseases, it"s the world"s biggest intervention against these conditions. It’s utterly important to show the world the importance of healthy life style, and the influence of bad habits on the cardiovascular system. >>>






    The Congress is held with the purpose to assist in realization of the national policy of healthcare system modernization, improvement of specialized medical services, reduction of cardiovascular morbidity and mortality that heads the list of conditions in the structure of general mortality in Russia and equals to 60%.

    This is an annual event of the most influential professional association of doctors. It is the largest and the most significant event for Russian cardiologists and doctors of related specialties.






    MAIN NEWS of ESC 2015

    Five new practice Guidelines for 2015

    Infective Endocarditis;Pericardial DiseaseAcute Coronary Syndromes (ACS)Pulmonary Hypertension;Arrhythmias

    PLATFORM: CT-Derived FFR Reduces Unnecessary Caths in Stable CAD

    Central Sleep Apnea Therapy Neutral on Outcomes but Hints at Increased Mortality

    PARAMETER: LCZ696 Bests Omesartan in Decreasing Arterial Stiffness in Elderly

    OptiLink HF: Remote Intrathoracic Impedance Monitoring Doesn"t Improve Survival

    CV-Outcomes Trials With Diabetes Drugs: "A Waste of Resources"


    ESC Congress 2015

    Saturday 29 August - Wednesday 02 September 2015 (5 Days), London - United Kingdom

    Final Programme

    Male Physicians More Likely to Be Targets of Legal Action


                                            Male physicians worldwide are nearly two and half times more likely to have medical-related legal action taken against them than their female counterparts, according to researchpublished online August 13 in BMC Medicine. Emily Unwin, a PhD candidate in the medical school at University College London in the United Kingdom, and colleagues did a meta-analysis of 32 studies and found a pooled odds ratio of 2.45 (95% confidence interval [CI], 2.05 - 2.93) that men were more likely the targets of action.>>>

    2015 toolkit now available

    The World Heart Day 2015 toolkit is now available for World Heart Federation members to download on our website. The toolkit provides you with a range of documents to support your activities, from organizing your World Heart Day events and liasing with the media, to guidance on how you can use World Heart Day in your advocacy efforts.

    To download the toolkit simply go to the World Heart Day materials and resources page and login as a member. You can then click the link to download using the user name and password supplied on the page.

    Please also remember to tell us about your World Heart Day plans by completing our simple online form.

    We hope you find this toolkit useful and that it helps and inspires you to organize World Heart Day activities in your region. If you require any further information please


    Copyright © World Heart Federation. All rights reserved.


    The Great Wall International Congress of Cardiology (GW-ICC) was founded in 1990 and gradually developed from a rarely known academic training class into a promotion conference of PCI &CABC and from a simple technical exchange meeting into the largest and one of the most influential and successful comprehensive cardiovascular Congress with the most complete subject in the Asian-Pacific region.

    Cherishing the principle of academic, openness, leadership, transmission and service, holding the great banner of public welfare, prevention, standardization and innovation the GW-ICC has developed an extensive academic exchange and tight cooperation with the most influential international medical Organizations and groups. Now the GW-ICC represents more than 13 thousand cardiology professionals from hospitals of all levels including many well-known experts or scholars all over the nation and has been committed itself in promoting in-depth exchange and extensive communication in the industry, cultivating professionals, bringing forth the outstanding figures and advancing together with the time and the whole world.>>>



     American Heart Association


    Educational projects

    About Heart Failure (HF)

    Heart failure occurs when the heart muscle is weakened and cannot pump enough blood to meet the body"s needs for blood and oxygen. Learn more about how this can develop.

    Understand Your Risk of Heart Failure
    Heart failure is one of the most common reasons for hospital admissions among those 65 years and older. But this condition is not limited to seniors. Learn more about who is at risk.

    Symptoms and Diagnosis of Heart Failure
    You may notice a shortness of breath, especially when lying down, swelling in the feet and ankles or a sudden weight gain. It is important to understand the symptoms and how to work with your healthcare provider for an accurate diagnosis.

    Warning Signs of Heart Failure
    Heart failure requires you to pay close attention to changes in symptoms. Reduce your chances of hospital visits by understanding your symptoms and knowing when they signal trouble. Learn what warning signs to watch for.

    Advanced Heart Failure
    For advanced heart failure patients and their doctors, making good decisions requires teamwork. Learn the treatment options, the planning involved and about shared decision making.

    Prevention and Treatment of Heart Failure 
    When heart failure is caused by heart damage that has developed over time, it can"t be cured. But there is good news. It can be treated and symptoms can improve. Learn more about prevention and treatment for heart failure.


    There are more than 1 million heart failure-related hospitalizations every year. Learn how to identify symptoms as early as possible here and help the cause:




    Global Heart edition: CVD Roadmaps 

    Three CVD Roadmaps dedicated to secondary prevention, tobacco control and raised blood pressure have been developed by the World Heart Federation and are now available in our journal Global Heart.

    The Roadmaps are designed to translate existing knowledge of best practices, barriers, and solutions into practical strategies for improved cardiovascular health. They serve as models so countries can meet their commitments to develop or update national non-communicable disease plans using the framework provided by the World Health Organization’s Global Action Plan (GAP).
    A platform has been developed to allow people to explore the roadmaps and input to share experience.
    Read more about the Roadmaps:

    View the Global Heart edition here

    Share your experience and build roadmaps on our interactive microsite:
    For additional information please contact:




                 All forms of smoking are bad for the heart

    Electronic cigarettes, shisha, cigars, cigarettes and passive smoking should be avoided 

    “Smoking of all types is still, without any competition, the strongest risk factor for cardiovascular disease. It beats everything. There has been a lot of research over the past 2-3 years which makes us very clear that all tobacco use, including the waterpipe, smokeless tobacco and electronic cigarettes, is simply not good for your health.”said ESC prevention spokesperson Professor Joep Perk.

    Studies suggest that waterpipe smoking, also referred to as shisha and hookah, may be associated with even greater toxin exposure because sessions are longer and involve more and larger “puffs”, leading to smoke inhalation as much as 100 times more than from a cigarette.>>>



        HFA Eugene Braunwald Lecture

        at Heart Failure 2015 

    The Heart Failure Association (HFA) is pleased to launch the HFA Eugene Braunwald Lecture at Heart Failure 2015.

    During the Inaugural Session on Saturday 23 May in Seville, delegates will have the unique opportunity to hear Eugene Braunwald, a major force in cardiology over the past 60 years, deliver his eponymous lecture titled: "Eugene Braunwald Lecture on heart failure: the path to an angiotensin receptor antagonist: neprilysin inhibitor">>>




    The IV International Forum of Cardiology and Internal Medicine has successfully concluded.  It was held between 30 March and 1 April 2015 in Moscow, in the new building of the Presidium of the Russian Academy of Sciences.  The Forum, dedicated to the Year of the fight against cardiovascular disease, was supported by the Ministry of Healthcare of the Russian Federation, World Heart Federation, Department of Healthcare of Moscow, Ministry of Healthcare of Moscow Region, Russian Society of Cardiology, and the Cardioprogress Foundation.

    The Forum was attended by 1,436 experts, including 63 visitors from neighbouring countries (Estonia, Latvia, Belarus, Moldova, Uzbekistan, Kazakhstan, Kyrgyzstan, Azerbaijan), and the far abroad (USA, Italy, Turkey, Israel).For the official participation of specialists in the Forum, decrees were issued by the Ministry of Healthcare of the Russian Federation, Department of Healthcare of Moscow, and the Ministry of Healthcare of Moscow Region.For the first time, the Forum participants had an opportunity to get a certificate with 15 continuing medical education (CME) points, according to the official system of calculatingCME points. All Forum participants and delegates registered and were given information materials free of charge.>>>







    Dear veterans! Esteemed colleagues!

    On behalf of the Cardioprogress Foundation I sincerely congratulate you with the great Victory Day!

    Our fathers and grandfathers went through the epic battlefields suffering from the endless losses and hardships of war towards the long-awaited veritable national Victory. This is the day when the world recalls with gratefulness the remarkable role that belonged to our country in freeing mankind from fascism.

    On Victory Day we bow our heads to millions of victims who died during the Great Patriotic War, we recall deeds of valor of those who brought the victory and those who were on the home front.

    We will always remember the high price given to save the mankind. You brought peace and freedom to your country and European people, disputed every inch of ground and defended the right to live for your children and grandchildren. Your incredible feat of arms will always serve as an example of true love to your country and steely determination.

    Congratulations on the Victory Day!


    Vice president of the Cardioprogress Foundation, 

    professor Mekhman N. Mamedov


    3D Printing in Cardiovascular Medicine

    3D printing is a compelling new technology that has the potential to revolutionize cardiac interventions. We are eager to hear how this innovative technology will enhance our knowledge and understanding of structural heart disease. To start, what is 3D printing?>>>

      ESC in Abu Dhabi at the 20th Asian Pacific Society Congress 

    THE "ESC IN ABU DHABI" PROGRAMME will include the main messages from multi-centric clinical trials and key points presented in the new ESC Guidelines at ESC Congress. 

    Sessions will include clinical cases with time for questions, discussion and debate.

    Sessions on the latest guidelines will include:

    • A cardiac patient undergoing colectomy
    • A patient with new onset atrial fibrillation
    • A diabetic patient undergoing revascularization

    Key topics covered include Heart failure cardiomyopathy, Arrhythmias, Valve disease, Imaging, Interventional cardiology, Risk factors. 



    Information letter                                Welcome address                           Registration form


    Cardiovascular disease kills 51% of women in Europe and breast cancer kills 3%


      Sophia Antipolis, 5 March 2015: Cardiovascular disease (CVD) kills 51% of women in Europe and breast cancer kills 3%, bucking the misperception that CVD is a man’s disease. CVD is the top killer in women and is largely preventable. The call for women to reduce their risk comes from the European Society of Cardiology (ESC) today on International Women’s Day.

    Dr Susanna Price, ESC spokesperson and consultant cardiologist at the RoyalBromptonHospital in London, UK, said:

    “CVD is still largely considered a man’s problem with breast cancer commonly perceived as the greater issue for women. However, CVD is the top killer of women in Europe, resulting in 51% of deaths compared to 3% caused by breast cancer.” >>>


            American College of Cardiology

    To continue with the theme of prevention, this week’s Heart Month post on the ACC in Touch Blog is focused on how to talk to patients about smoking cessation in order to reduce risk of heart disease:




    Now Available
    Heart Disease and Stroke Statistics-2015 Update

    Highlights from the AHA 2015 Statistical Update1:

    • The overall rate of death attributable to CVD was 229.6 per 100,000. 
    • More than 2150 Americans die of CVD each day, an average of 1 death every 40 seconds.
    • Stroke accounted for ≈1 of every 20 deaths in the United States. 
    • 32.6% of US adults have hypertension. That"s 80 million adults.
    • An estimated 30.9 million adults have total serum cholesterol levels ≥240 mg/dL.
    • Among adults in the United States, 1 in 5 men and 1 in 6 women are current smokers.
    • Younger adults are more likely to meet greater numbers of ideal metrics than are older adults.
    • More than 60% of Americans >60 years of age have ≤2 metrics at ideal levels. At any age, women tend to have more metrics at ideal levels than do men. 
    • Blacks and Mexican Americans tend to have fewer metrics at ideal levels than whites or other races. Approximately 6 in 10 white adults and 7 in 10 black or Mexican American adults have no more than 3 of 7 metrics at ideal levels.


      This American Heart Association statistical report tracks global                                       figures for the first time. 


    2015 MOC Standards Reflect Feedback, Fail to Stem Critics



    Two articles published in the January 8 issue of the New England Journal of Medicine outline very different perspectives on maintenance of certification (MOC).

    Mira Irons, MD, senior vice president for academic affairs for the American Board of Medical Specialties (ABMS), and Lois Nora, MD, JD, ABMS president and chief executive officer, say MOC is necessary self-regulation and a critical measure of physician expertise as healthcare becomes exponentially more complex.>>>






    Two Guidelines Added to ACC Guideline Clinical App

    WASHINGTON (Dec. 12, 2014) — The American College of Cardiology’s recently released Guideline Clinical App has expanded with the addition of tools and guideline content for two conditions,  valvular heart disease and atrial fibrillation.

    The ACC Guideline Clinical App was launched in November with the initial version including content based on guidelines for heart failure, cardiovascular risk assessment, and treatment of blood cholesterol. In addition to the Executive Summary and Top 10 Points for each guideline, the app includes a collection of interactive tools such as dosing calculators, scoring tools, and algorithms useful to clinicians in determining recommended care. 

    The ACC, which has been developing clinical practice guidelines in partnership with the American Heart Association for more than three decades, developed this app to serve as a mobile home for all ACC/AHA guideline content and related tools.>>>


    Report from IV Cardionale

    November 7-8, 2014 in Prague hosted Cardionale dedicated to thr complex management of the total cardiovascular risk. The conference was attended by 150 cardiologists from 22 countries. The scientific program included talks by leading experts the US, Europe and Russia. More information on




    CVD Taskforce calls for the inclusion of cardiovascular disease in UN Sustainable Development Goals


    In a statement published in the Global Heart Journal, the Global Cardiovascular Disease Taskforce calls on governments to ensure a strong focus on health, non-communicable diseases (NCDs) and other areas critical to the global prevention and control of cardiovascular disease (CVD), by including them in the United Nations Sustainable Development Goals>>>
      National Library of Medicine (NLM)

     Islamic Medical Manuscripts at the National Library of Medicine ( helps you learn about Islamic medicine and science during the Middle Ages and the important role it played in the history of Europe. With its biographies, colorful images and extensive historical accounts of medieval medicine and science, the site is designed for students, scholars and anyone interested in the history of Islamic and European culture.

      American College of Cardiology. Pro-Substance P for Evaluation of Risk in Acute Myocardial Infarction

    Pro-Substance P for Evaluation of Risk in Acute Myocardial Infarction



    Nobel Prize in Medicine is Awarded for Discovery of Brain’s ‘Inner GPS’

    John O"Keefe, Edvard Moser, and May-Britt Moser, from left, were announced as winners of the Nobel Prize in Medicine on Monday (Oct.6, 2014)

    A British-American and two Norwegian scientists were awarded this year’s Nobel Prize in Physiology or Medicine for discovering brain circuits that form an “inner GPS” system that allows us to navigate our environment.

    Half the prize was awarded to American-born John O’Keefe for discovering nerve cells that get activated in different combinations to enable the creation of a spatial map that determines our sense of “place.”>>>




    World Heart Day was founded in 2000 to inform people around the globe that heart disease and stroke are the world’s leading causes of death, claiming 17.3 million lives each year. 

    World Heart Day is an annual event which takes place on 29 September every year. Each year’s celebrations have a different theme, reflecting key issues and topics relating to heart health. 2014’s theme is creating heart-healthy environments (see below).

    Together with World Heart Federation members, World Heart Day spreads the news that at least 80% of premature deaths from cardiovascular disease (CVD) could be avoided if four main risk factors – tobacco use, unhealthy diet, physical inactivity and harmful use of alcohol – are controlled. 

    The success of World Heart Day depends on the proactivity of organizations from around the world to help us spread awareness of CVD, the world’s number one killer. 

    The campaign of Russian cardiologists (Moscow, Auchan supermarket)




    The Russian National Congress of Cardiology was  held on 24-26 September 2014 in Kazan. At the Congress, 3,913 participants  from 191 cities registered , representing all regions of the Russian Federation. The Congress was also attended by 186 foreign visitors from 25 countries.

    In total at the Congress, there were 170 scientific sessions - 12 plenary sessions, 127 symposia , 11 educational schools ,  9 breakout sessions ,  3 master classes , 3  discussion club s ,  3 round tables ,  1 workshop and 1 scientific session, which were devoted to the most acute problems in prevention and treatment of cardiovascular disease.

    More information is available at


    Photo report from the European Congress of Cardiology

    (Barcelona, August 30 - September 3, 2014)




    Health care professionals should use a 14-element checklist when evaluating healthy, young individuals ages 12-25 for congenital and genetic heart disease vs initial screening using electrocardiograms, according to a new scientific statement released by the ACC and the American Heart Association and published in the Journal of the American College of Cardiology. Full coverage:


    Dear Colleagues,

    We are pleased to inform you that the Cardioprogress Foundation fourth year takes an active part in the work of the European Congress of Cardiology (Barcelona, 30 August- 3 September, 2014).

    The exhibition, organized by the European Congress of Cardiology Cardioprogress Foundation will be presented with an individual booth (booth number C400 - the area of international organizations). On the stand is scheduled presentation of new books, the third edition of the International Journal of heart and vascular diseases, preliminary program of the IV International Forum cardiologists and internists and souvenirs. Will be glad to see you among the active members of the European Congress of Cardiology.

            ESC CONGRESS 2016, the world’s largest and most influential cardiovascular meeting, promises to feature world class science that will be more interactive than ever before. Over the next five days 150 different topics will be covered in over 500 sessions attended by over 30,000 professionals from 106 countries. ‘We warmly welcome everyone to ESC Congress 2016, held for the first time in the eternal city of Rome,’ says Geneviève Derumeaux, Chair of the Congress Programme Committee. ‘I think that the ethos of ESC Congress can be summarised by the words of the great Italian film director Federico Fellini. ‘‘There is no end. There is no beginning. There is only the infinite passion of life.’’ For me, this shows how all the advances in cardiovascular medicine are based on the tireless work of clinicians and scientists who went before.’

    As ever, the big highlight will be original research, with the programme including:

    • 28 clinical Hot Line studies

    • 26 clinical trial updates

    • 24 registry studies

    • 12 basic and translational science Hot Lines

    • 4594 abstracts selected from more than 11,000 submissions.


    See more: 



    The ACC, in partnership with the American Diabetes Association, theAmerican College of Physicians (ACP), and Joslin Diabetes Center is launching the Diabetes Collaborative Registry, the first clinical registry aimed at tracking and improving the quality of diabetes and  cardiometabolic care across the primary and specialty care continuum.


    Cardioprogress Foundation congratulates Eugene Shlyakhto, President of the Russian Society of Cardiology, academician of the Russian Academy of Sciences, Director of the Federal Almazov Medical Research Centre, with his Jubilee.

    Way to the Top: a brief biography

    Evgeny Shlyakhto was born in 1954.  He graduated from the 1st Leningrad Pavlov Medical Institute in 1977.  He became a Doctor of Medical Sciences in 1992, Professor in 1994, Honoured Scientist of the Russian Federation in 2004, Academician of the Russian Academy of Medical Sciences in 2011, Academician of the Russian Academy of Sciences in 2014.

    Evgeny Shlyakhto is Director of the Federal Almazov Medical Research Centre (2001 – present), Chair of Faculty Therapy Department at the Pavlov First Saint Petersburg State Medical University (1997 – present), and President of the Russian Society of Cardiology (2011 – present).  He is also Chief Cardiologist of St. Petersburg (from 2001 to present) and the North-West Federal District (2002-present).  In 2010 Shlyahto joined the working group of WHO experts. >>>

    Preventing Childhood Obesity: Tips for Parents and Caretakers
      Balance is key in helping your child maintain a healthy weight. Balance the calories your child eats and drinks with the calories used through physical activity and normal growth.
    Overweight and obese children and teens should reduce the rate of weight gain while allowing normal growth and development. Don’t put your child on a weight-reduction diet without talking to your health care provider. >>>



    Hot Topic: The importance of evaluating CV risk in men with erectile dysfunction is now a critical factor for overall early stage management of CVD.


    Which New Hypertension Guidelines Are the Best?

    ATHENS, GREECE — Should guidelines educate or merely inform? Should they rely on the most rigorous randomized-clinical-trial (RCT) evidence or leave ample room for expert opinion? Whose guidelines, among the three separate sets of recommendations released in the past year, are the best?

    Those were the key questions to emerge during a special session here at HYPERTENSION 2014 , the joint conference of the European Society of Hypertension (ESH) and theInternational Society of Hypertension (ISH), dedicated to the 2013 ESH/European Society of Cardiology(ESC) guidelines, the JNC 8/JAMA guidelines, and theAmerican Society of Hypertension (ASH)/ISH guidelines         >>>



    Dear Colleagues!
    This year’s World Congress of Cardiology took place in Melbourne between 4-7 May 2014. The organizers of the Congress included the World Heart Federation (headquartered in Geneva) and the Cardiac Society of Australia and New Zealand, together with local assistance.

      More than 15,000 delegates from over 60 countries attended the Congress.  The scientific programme included educational seminars, symposia, discussions, analyses of clinical cases, joint scientific meetings of national and international societies – members of the World Heart Federation – and poster sessions. >>>



      World Congress of Cardiology Scientific Sessions 2014 
    Salt and Battery: Debate on Sodium Targets Gets Feisty  

    Michael O’Riordan

    MELBOURNE, AUSTRALIA — An analysis of more than 100 000 participants in the Prospective Urban Rural Epidemiology (PURE) study is once again stoking the debate over what level of sodium intake is good for human health. The latest data from PURE suggest that both low and high levels of sodium intake are associated with an increased risk of mortality and cardiovascular events in individuals with and without hypertension.

    Presenting the results of the analysis at the World Congress of Cardiology 2014 Scientific Sessions, lead investigator Dr Salim Yusuf (McMaster University, Hamilton, ON) said that individuals who consumed between 3000 mg and 6000 mg of sodium per day had the lowest risk of death and cardiovascular mortality but that there is a U- or J-shaped association between sodium intake and adverse clinical outcomes at higher and lower levels of sodium intake, where mortality and cardiovascular events are increased >>>


    Dear Colleagues,

    We are pleased to inform you that the Cardioprogress Foundation takes active part in the World Congress of Cardiology (Melbourne, 4-7 May 2014).

    First time in the scientific program, the symposium Cardioprogress Foundation involving Russian and American experts. The theme of the symposium "Long-term trends of CVD prevention, risk and mortality in different countries" Chairs: Mamedov MN (Russia), Ann Bloger (USA). Time and place of the symposium: 10.30-12.00, May 7, 2014 (Room No105-106).

    Cardioprogress Foundation also participates in the exhibition with an individual booth (Booth No C25 - the area of international members of the World Heart Federation). Will be glad to see you among the active participants in the World Congress of Cardiology.

    Social advertising of Canadian Heart and Stroke Foundation. Work out now!


    Dear colleagues!

    We inform you that in 2014 the Foundation for the advancement of cardiology "Cardioprogress" has been accepted as an Associate National Member of World Heart Federation.

    In January 2014 in Geneva at the headquarters of the World Heart Federation has been reached between the relevant agreement as CEO of the Federation Johanna Ralston and Vice President of the Foundation Professor Mekhman N. Mamedov. 

    Below is an official document of the Cardioprogress Foundation"s membership in the World Heart Federation.
    An official letter from the CEO of the World Heart Federation.
      An increasing number of patients with cancer and cancer survivors are living with cardiovascular disease. Pre-existing cardiac condition or risk factors may limit available therapeutic options for cancer treatment, while cancer therapies, or cancer itself, may lead to development of cardiovascular complications thus impacting patients’ outcomes. With the development and widespread use of novel, molecularly-targeted cancer therapies there has been an increased recognition of their cardiovascular adverse effects, spanning from hypertension, asymptomatic left ventricular dysfunction and QT prolongation to clinical heart failure, arrhythmia and vasculopathy.

    Read more about this hot topic:  
    The second issues of International Heart
    and Vascular Disease Journal
    Editor’s Welcome

      Dear Colleagues,

    The idea of creating an international journal in English and Russian languages has proved to be popular. The editors have received many positive reviews from Russian and foreign colleagues, who are interested in publishing articles in the journal.

    The second issue includes seven articles from different countries and focuses on the following aspects of cardiovascular disease:
    the value of endothelial nitric oxide synthase gene polymorphism in the development of coronary artery disease; the relationship between physical activity and cardiovascular risk; assessment of cardiovascular risk in the population of a large cities in Ukraine; an expert’s opinion on new US cardiovascular prevention guidelines; echocardiographic predictors of preservation of left ventricular function after surgery; and a clinical case of infectious myocarditis.

    The leading article presents results from a stroke register that evaluated therapy received by patients, and its impact on their long-term prognosis.

    We hope that the contents of this second issue will be useful for readers and welcome your comments, suggestions and articles.

    Yours sincerely, Rafael G.Oganov
    President, Cardioprogress Foundation
    Issues 2, 2014
        In the latest JACC President’s Page, new ACC President Patrick T. O’Gara, MD, FACC, shares how he will focus his presidency on identifying and developing the next generation of great leaders. According to O’Gara, “populating our leadership ranks now will help ensure the ascendancy of future generations that will be equipped to place the College and the profession on a course to meet the many local, national, and global challenges, while continuing to transform cardiovascular care, improve heart health, and promote wellness.” Read more:
    Openning Session of ACC.14
      Annual congress of The American College of Cardiology (ACC) was held in Washington on 29-31 March 2014. The opening session of ACC.14 is available on: >>>
      Unfortunately, following the standard of care doesn’t always protect physicians from medical malpractice. In this series of malpractice cautionary tales from The Doctors Company, attorneys discuss medical malpractice cases that went awry—and how physicians can protect themselves. 
    A Soda a Day Ups CVD Risk by 30%: NHANES Study
        ATLANTA, GA — American adults consume on average about 15% of their calories from sugars added to foods during processing, with a whopping 37% of the added sugar consumed in sugar-sweetened beverages, suggests an analysis of data extending back about 25 years. Moreover, the study projects that regularly drinking as little as one 12-ounce sugary soda a day may increase the risk of cardiovascular disease by about 30%—independent of total calories, obesity, or other risk factors >>>.  
    Love ’Em or Leave ’Em: Experts on Both Sides Debate the New Lipid Guidelines
        Michael O’Riordan

    DALLAS, TX and WASHINGTON, DC — It has been two months since the new clinical guidelines for the treatment of cholesterol were published, and feedback is starting to slowly emerge as clinicians begin incorporating the recommendations into clinical practice.

    The American College of Cardiology (ACC) and American Heart Association (AHA) guidelines, which were developed in conjunction with the National Heart, Lung, and Blood Institute (NHLBI), were a radical departure from previous iterations, most notably in their abandonment of LDL-cholesterol targets. In the past, clinicians were advised to treat patients with cardiovascular disease to less than 100 mg/dL or the optional goal of less than 70 mg/dL. >>>
    Russian National Congress of Cardiology 2013: facts and figures
      The Congress was held under the motto – Cardiology from science to practice

    Scientific Committee, led by Professor Albert S. Galyavich, included in the programme:
    • 6 plenary sessions
    • 28 plenary lectures
    • 140 poster presentations
    • 567 oral presentations
    • 138 sectional scientific sessions, symposia and clinical case studies

    During the Congress a series of recommendations developed by expert committees of the Russian Society of Cardiology (RSC) were adopted >>>
    Discussion of screening results of the Russian population

    (Meeting of Russian President Vladimir Putin and Minister of Health Veronika Skvortsova)
    At a recent meeting with President Vladimir Putin, Veronika Skvortsova, Head of the Ministry of Healthcare of the Russian Federation, noted that, according to the results of a recent medical examination of the population, over 30% of Russians are healthy, and the general condition of children in the past ten years has noticeably improved.

    According to Veronika Skvortsova, a two-stage clinical examination of the Russian population has been introduced. After a thorough screening almost one in four will go onto have a more detailed examination, including endoscopy, computed tomography and magnetic resonance imaging, ultrasound and laboratory tests. Veronika Skvortsova also noted that the main purpose of mass health examinations is to identify groups within the population who need preventive treatment, and thus provide a higher degree of adherence to treatment, no less than 60%... >>>
        New guidelines in USA:

    2013 ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk

    How do they compare with the EAS/ESC guidelines for the management of dyslipidaemia?

    Comment by EAS Guidelines Committee

    The AHA and ACC recently released three documents dealing with guidelines for the prevention of cardiovascular disease (CVD):1-3 one document on lifestyle management, one document on overweight and obesity and one document on “The treatment of blood cholesterol to reduce ath-erosclerotic cardiovascular risk in adults”. It is welcomed that updated guidance on the treatment of cholesterol is now available for the USA.

    In line with the guidelines published by EAS and ESC in 2011 for the management of dyslipi-daemias4 the AHA/ACC guidelines emphasize the importance of LDL cholesterol (LDL-C) re-duction in cardiovascular prevention, in both the primary and secondary prevention of CVD... >>>
    VIII National Congress of Internal Medicine: 
    a step towards integration into the international community
    VIII National Congress of Internal Medicine took place in Moscow on 20-22 November 2013. This year, the Russian Scientific Medical Society of Internal Medicine (RSMSIM) timed the Congress to coincide with an anniversary of its bright representative from the Moscow school of internal medicine – Valentina A. Nasonova. The Congress was held under the auspices of the International Society and European Federation of Internal Medicine... >>>
          American College of Cardiology 

    The ACC and the American Heart Association, in collaboration with the National Heart, Lung, and Blood Institute (NHLBI) and other specialty societies, have released four guidelines focused on the assessment of cardiovascular risk, lifestyle modifications to reduce cardiovascular risk and management of elevated blood cholesterol and body weight in adults. Get full coverage: http:\\\qKRHo






    Contact us: by  

    Main | About | International Forum of Cardiology and Internal Medicine | Russian Cardio Agenda | World Cardio Agenda | Educational projects | Guidelines | linical trials | Journals | News | Archive
    2012-2018. Foundation for Promotion of Cardiology